Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp.

Sumanpreet Kaur,Preeti Sharma,Namarta Kalia,Jatinder Singh,Sukhraj Kaur
DOI: https://doi.org/10.3389/fcimb.2018.00120
IF: 6.073
2018-04-24
Frontiers in Cellular and Infection Microbiology
Abstract:Diarrheal disease caused by <i>Vibrio cholerae</i> is endemic in developing countries including India and is associated with high rate of mortality especially in children. <i>V. cholerae</i> is known to form biofilms on the gut epithelium, and the biofilms once formed are resistant to the action of antibiotics. Therefore agents that prevent the biofilm formation and disperse the preformed biofilms are associated with therapeutic benefits. The use of antibiotics for the treatment of cholera is associated with side effects such as gut dysbiosis due to depletion of gut microflora, and the increasing problem of antibiotic resistance. Thus search for safe alternative therapeutic agents is warranted. Herein, we screened the lactobacilli spp. isolated from the fecal samples of healthy children for their abilities to prevent biofilm formation and to disperse the preformed biofilms of <i>V. cholerae</i> and <i>V. parahaemolyticus</i> by using an <i>in vitro</i> assay. The results showed that the culture supernatant (CS) of all the seven isolates of <i>Lactobacillus</i> spp. used in the study inhibited the biofilm formation of <i>V. cholerae</i> by more than 90%. Neutralization of pH of CS completely abrogated their antimicrobial activities against <i>V. cholera</i>, but had negligible effects on their biofilm inhibitory potential. Further, CS of all the lactobacilli isolates caused the dispersion of preformed <i>V. cholerae</i> biofilms in the range 62-85%; however, pH neutralization of CS reduced the biofilm dispersal potential of the 4 out of 7 isolates by 19-57%. Furthermore, the studies showed that CS of none of the lactobacilii isolates had antimicrobial activity against <i>V. parahaemolyticus</i>, but 5 out of 7 isolates inhibited the formation of its biofilm in the range 62-82%. However, none of the CS dispersed the preformed biofilms of <i>V. parahaemolyticus</i>. The ability of CS to inhibit the adherence of <i>Vibrio</i> spp. to the epithelial cell line was also determined. Thus, we conclude that the biofilm dispersive action of CS of lactobacilli is strain-specific and pH-dependent. As <i>Vibrio</i> is known to form biofilms in the intestinal niche having physiological pH in the range 6-7, the probiotic strains that have dispersive action at high pH may have better therapeutic potential.
immunology,microbiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore a safe and effective alternative treatment method for diarrheal diseases caused by Vibrio cholerae. Cholera remains a major public health problem in developing countries, especially in places like India, and is associated with a high mortality rate, especially among children. Vibrio cholerae can form biofilms on the intestinal epithelium. Once these biofilms are formed, they are resistant to immune defenses and antibiotics, leading to recurrent infections. Therefore, finding agents that can prevent biofilm formation or disperse formed biofilms is of therapeutic significance. The specific research questions of the paper are: 1. **Screening of lactic acid bacteria**: Do lactic acid bacteria isolated from fecal samples of healthy children have the ability to prevent biofilm formation by Vibrio cholerae and its closely related species Vibrio parahaemolyticus? 2. **Biofilm inhibition and dispersion capabilities**: Can the culture supernatants (CS) of these lactic acid bacteria inhibit biofilm formation in vitro experiments and disperse already - formed biofilms? 3. **Mechanism exploration**: Explore whether these effects of lactic acid bacteria are related to their metabolic products such as low pH values, and whether these effects are strain - specific. Through these studies, the paper aims to develop candidate strains that can be used as indigenous probiotics for the prevention and treatment of intestinal infections caused by Vibrio cholerae and other pathogenic vibrios, especially considering the possible side effects of antibiotic use, such as intestinal flora imbalance and increased antibiotic resistance.